Culver, Emma L

European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations

Löhr, J., Beuers, U., Vujasinovic, M., Alvaro, D., Frøkjær, J. B., Buttgereit, F., Capurso, G., Culver, E. L., de‐Madaria, E., Della‐Torre, E., et al. (2020) · United European Gastroenterology Journal

IgG4-Related and Inflammatory DiseasesPancreatitis Pathology and Treatment

Cited by 252

Exposure to occupational antigens might predispose to IgG4-related disease

de Buy Wenniger, L. J. M., Culver, E. L., & Beuers, U. (2014) · Hepatology

IgG4-Related and Inflammatory DiseasesLiver Diseases and Immunity

Cited by 124

The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases

Cargill, T., & Culver, E. L. (2021) · Frontiers in Immunology

Liver Diseases and ImmunityIgG4-Related and Inflammatory Diseases

Cited by 46

Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?

Jones, D. E. J., Beuers, U., Bonder, A., Carbone, M., Culver, E., Dyson, J., Gish, R. G., Hansen, B. E., Hirschfield, G., Jones, R., et al. (2024) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 38

Experience from the First UK Inter-Regional Specialist Multidisciplinary Meeting in the Diagnosis and Management of IgG4-Related Disease

Goodchild, G., Peters, R. J., Cargill, T. N., Martin, H., Fadipe, A., Leandro, M., Bailey, A., Collier, J., Firmin, L., Chouhan, M., et al. (2020) · Clinical Medicine

IgG4-Related and Inflammatory DiseasesSystemic Sclerosis and Related Diseases

Cited by 13

Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid

Dunn, S., Evans, L., Kennedy, C., Wafer, R., Moody, S., Wolstenhulme, F., Burton, E., Konkoth, A. B., Fisher, H., Chadwick, T., et al. (2026) · BMJ Open

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 0